Skip to main content
. 2022 Jan 28;23(3):1539. doi: 10.3390/ijms23031539

Figure 5.

Figure 5

Analysis of protein expression of CAP2, SAP97, and ADAM10 in the post-mortem dorsolateral prefrontal cortex and hippocampus of schizophrenia patients. Quantification of CAP2, SAP97, and ADAM10 protein levels in the total homogenates of post-mortem (a–c) dorsolateral prefrontal cortex (DLPFC) and (e–g) hippocampus of schizophrenic subjects (SCZ, n = 20) and control group (CTRL, n = 20). The variations of CAP2, SAP97, and ADAM10 levels in schizophrenic patients are expressed as a percentage (%) of the control subjects. All markers were normalized to GAPDH for variations in loading and transfer. (d,h) Representative images of immunoblots of CAP2, SAP97, ADAM10 performed in the DLPFC and hippocampus of the control group and schizophrenia patients. Each dot represents values from a single subject. All experiments were analyzed by the Mann–Whitney test.